Regulatory Relief for Certain Stationary Sources To Promote American Security With Respect to Sterile Medical Equipment

Healthcare Energy & Environment Defense & Security Economy & Labor

In simple terms

This proclamation grants a 2-year exemption from EPA ethylene oxide (EtO) emissions-control requirements for certain commercial sterilization facilities, extending all compliance deadlines under the April 2024 EtO Rule. The President determines that required emissions-control technology is not commercially viable and that the existing compliance timeline threatens national security by risking closure of facilities that sterilize roughly half of all U.S. medical devices.

Federal Register Open PDF 90 FR 34747

Record & deadlines

Jul 17, 2025Signed
Signed by the President
Jul 23, 2025FR published
Published in the Federal Register · 90 FR 34747
Federal Register PDF
Apr 5, 2026
Approximate earliest extended compliance deadline (if original was April 5, 2024 + typical compliance period; exact dates depend on original EtO Rule deadlines)
Jul 17, 2025
2-year exemption from each original EtO Rule compliance date for Annex I sources

Market exposure

Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

Sectors

Pharma Other industrial

Mechanisms

Ban / prohibition

Role pressure

ProtectiveDomestic producer — Sterilization facilities avoid capital expenditures on non-viable emissions controls and potential closure; operational continuity protected
ProtectiveDownstream manufacturer — Medical device manufacturers retain access to critical EtO sterilization capacity, avoiding supply disruption for approximately 50% of sterile devices
AdverseEquipment supplier — Firms developing emissions-control technologies for EtO sterilization lose near-term regulatory-driven demand; market development delayed 2 years

Geographies

Illustrative public companies

Curated watchlist matches by sector/role — incomplete; not a recommendation.

MMM3MAAPLAppleCATCaterpillarLLYEli LillyFCXFreeport-McMoRanGEVGE VernovaHONHoneywellJNJJohnson & JohnsonMRKMerckNVSNovartisPFEPfizerSPYSPDR S&P 500 ETF

Confidence: medium · Policy alerts

Key directives

Grant 2-year exemption from EtO Rule compliance for stationary sources listed in Annex I
Extend all applicable EtO Rule compliance deadlines by 2 years from original required dates
Maintain pre-EtO Rule emissions and compliance obligations during exemption period
Determine that commercially viable emissions-control technology does not exist
Determine that exemption serves national security interests

Who is ordered

President of the United States · Executive Office of the President

Prior policyRollback

otherEPA EtO Rule (89 FR 24090, April 5, 2024)

What to expect

Immediate

Exemption takes effect upon proclamation; covered facilities remain under pre-EtO Rule emissions obligations

Near term (90d)

Facilities avoid imminent compliance deadlines that would have forced closures

Long term

2-year exemption period runs from each original EtO Rule compliance date; eventual need for viable technology or further regulatory action

Risks & tensions

Legal challenge risk: EPA rulemaking via proclamation may face Clean Air Act procedural challenges; section 112(i)(4) authority for technology-based delays is untested at this scale
Public health tension: EtO is a known carcinogen; exemption prolongs community exposure near sterilization facilities
Annex I not provided in text: scope of affected facilities is unclear without the annex
Supply chain vs. environmental protection: document frames this as national security imperative but minimizes environmental compliance costs